← Back to Search

HLWD for Type 2 Diabetes

N/A

Waitlist Available

Led By Olayinka Shiyanbola, MD

Research Sponsored by University of Wisconsin, Madison

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, 2 months, 6 months

Awards & highlights

Study Summary

This trial is testing whether a new diabetes self-management program is more effective than the existing program.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, 2 months, 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, 2 months, 6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 2 months, 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in blood glucose (hemoglobin A1C)

Secondary outcome measures

Acceptability of intervention

Adherence to Refills and Medicines Scale for Diabetes (ARMS-D) Score

Feasibility of intervention

+1 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Peers EXCELExperimental Treatment2 Interventions

Participants will have an 8-week self-management program, and will participate in phone calls with a peer for the remaining 4 months.

Group II: Healthy Living with Diabetes (HLWD)Active Control1 Intervention

Participants will have a 6-week self-management program, followed by the option to work with a Community Health Worker for the remaining 4 months.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Peers LEAD

2023

N/A

~20

HLWD

2023

N/A

~20

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of Wisconsin, MadisonLead Sponsor

1,182 Previous Clinical Trials

3,167,373 Total Patients Enrolled

Olayinka Shiyanbola, MDPrincipal InvestigatorUniversity of Wisconsin, Madison

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any remaining vacancies for this clinical trial?

"According to the details accessible on clinicaltrials.gov, this research is not admitting new subjects presently. It was published on January 1st 2023 and last revised November 14th 2022. Although no recruitment is occurring for this trial currently, there are 374 other studies that require participants right now."

Answered by AI

Can I be part of this scientific exploration?

"This clinical trial is seeking 24 volunteers with type 2 diabetes mellitus between the ages of 18 and 90. Qualifying applicants will be accepted to participate in this study."

Answered by AI